← Back to Search

Neurostimulation

Electrophysiology assessment - corticospinal tract for Spinal Cord Injury

N/A
Waitlist Available
Led By Ismael Seanez, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes before and 30 minutes into intervention
Awards & highlights

Study Summary

This trial will test if re-enabling movement of paralyzed areas is possible using transcutaneous spinal cord stimulation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes before and 30 minutes into intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes before and 30 minutes into intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in corticospinal tract excitability after training
Changes in reticulospinal tract excitability after training

Trial Design

2Treatment groups
Experimental Treatment
Group I: Reaction time evaluation during non-invasive spinal cord stimulation and leg movementsExperimental Treatment2 Interventions
This arm will receive the loud auditory stimuli to evaluate the excitability of the reticulospinal tract first then the arm will receive the transcranial magnetic stimulation to excite the corticospinal tract second
Group II: Evaluation of motor evoked potentials during non-invasive spinal cord stimulation and leg movementsExperimental Treatment2 Interventions
This arm will receive the transcranial magnetic stimulation to evaluate the excitability of the corticospinal tract first then the arm will receive the loud auditory stimuli to evaluate the excitability of the reticulospinal track second.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,945 Previous Clinical Trials
2,303,800 Total Patients Enrolled
Ismael Seanez, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
120 Total Patients Enrolled
~7 spots leftby May 2025